SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 16th, 2014 • Skystar Bio-Pharmaceutical Co • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of July 14, 2014, between Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
COMMON STOCK PURCHASE WARRANT skystar bio-pharmaceutical companyCommon Stock Purchase Warrant • July 16th, 2014 • Skystar Bio-Pharmaceutical Co • Pharmaceutical preparations
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after January __, 2015 (the “Initial Exercise Date”) and on or prior to the close of business on the one year anniversary of the Initial Exercise Date (the “Termination Date”) but not thereafter, to subscribe for and purchase from Skystar Bio-Pharmaceutical Company, a Nevada corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
STRICTLY CONFIDENTIAL Weibing Lu Chairman of the Board Skystar Bio- Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road Gaoxin District, Xi’an Province, P.R. China Dear Chairman Lu:Placement Agent Agreement • July 16th, 2014 • Skystar Bio-Pharmaceutical Co • Pharmaceutical preparations • New York
This letter agreement (this “Agreement”) constitutes the agreement between Skystar Bio-Pharmaceutical Company (the “Company”) and H.C. Wainwright & Co., LLC (“Wainwright”) that Wainwright shall serve as the exclusive placement agent in a registered direct offering (“Offering”) of securities of the Company (“Securities”) during the Term (as defined below) of this Agreement. The terms of the Offering and the Securities issued in connection therewith shall be mutually agreed upon by the Company and Wainwright and nothing herein implies that Wainwright would have the power or authority to bind the Company and nothing herein implies that the Company shall have an obligation to issue any Securities. It is understood that Wainwright’s assistance in an Offering will be subject to the satisfactory completion of such investigation and inquiry into the affairs of the Company as Wainwright deems appropriate under the circumstances and to the receipt of all internal approvals of Wainwright in conne
